Skip to main content

Receptor Serine/Threonine Kinases

  • Reference work entry

Definition

Receptor serine/threonine kinases (RSKs) are transmembrane proteins of the plasma membrane and are characterized by extracellular ligand‐binding domains and cytoplasmic kinase domains. All RSKs of the human genome act as signaling receptors for members of the transforming growth factor β (TGF‐β) superfamily of secreted polypeptides (5). Accordingly, RSKs are known to play major roles in multiple physiological and pathological processes of metazoan life, including early embryogenesis, adult tissue homeostasis, atherosclerosis, tissue fibrosis and cancer (1, 3).

Characteristics

Type I and Type II RSKs

RSKs can be divided into two subgroups, the type I and type II RSKs, based on primary amino acid sequence comparison (5). Upon ligand binding, a heteromeric complex of type I and type II receptors are formed, in which the type II RSK phosphorylates and activates the type I RSK. Type I RSKs therefore play the major role in activating downstream effectors of the signaling pathway....

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   799.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   799.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Chang H, Brown CW, Matzuk MM (2002) Genetic analysis of the mammalian transforming growth factor‐β superfamily. Endocr Rev 23:787–823

    Article  PubMed  CAS  Google Scholar 

  2. Derynck R, Zhang YE (2003) Smad‐dependent and Smad‐independent pathways in TGF‐β family signalling. Nature 425:577–584

    Article  PubMed  CAS  Google Scholar 

  3. Dijke P ten, Goumans M‐J, Itoh F et al (2002) Regulation of cell proliferation by Smad proteins. J Cell Physiol 191:1–16

    Article  PubMed  CAS  Google Scholar 

  4. Moustakas A, Souchelnytskyi S, Heldin C‐H (2001) Smad regulation in TGF‐β signal transduction. J Cell Sci 114:4359–4369

    PubMed  CAS  Google Scholar 

  5. Piek E, Heldin C‐H, ten Dijke P (1999) Specificity, diversity, and regulation in TGF‐β superfamily signaling. FASEB J 13:2105–2124

    PubMed  CAS  Google Scholar 

  6. Shi Y, Massagué J (2003) Mechanisms of TGF‐β signaling from cell membrane to the nucleus. Cell 113:685–7006

    Article  PubMed  CAS  Google Scholar 

  7. Souchelnytskyi S, Moustakas A, Heldin C‐H (2002) TGF‐β signalling from a 3‐dimensional perspective: insight into selection of partners. Trends Cell Biol 12:304–307

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carl‐Henrik Heldin .

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag

About this entry

Cite this entry

Moustakas, A., Souchelnytskyi, S., Heldin, C. (2005). Receptor Serine/Threonine Kinases. In: Encyclopedic Reference of Genomics and Proteomics in Molecular Medicine. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-29623-9_3130

Download citation

Publish with us

Policies and ethics